Jailendra Singh
Stock Analyst at Truist Securities
(1.01)
# 3,936
Out of 5,133 analysts
184
Total ratings
31.31%
Success rate
-22.75%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDLN Medline | Initiates: Buy | $52 | $42.72 | +21.72% | 1 | Jan 12, 2026 | |
| IQV IQVIA Holdings | Maintains: Buy | $265 → $290 | $240.86 | +20.40% | 18 | Jan 8, 2026 | |
| ICLR ICON Public Limited Company | Downgrades: Hold | $231 → $222 | $180.15 | +23.23% | 11 | Jan 8, 2026 | |
| FTRE Fortrea Holdings | Upgrades: Buy | $12 → $22 | $18.40 | +19.57% | 1 | Jan 8, 2026 | |
| PRVA Privia Health Group | Reiterates: Buy | $30 → $31 | $23.44 | +32.28% | 8 | Nov 10, 2025 | |
| EVH Evolent Health | Maintains: Buy | $16 → $10 | $4.15 | +140.96% | 8 | Nov 10, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $436 → $555 | $599.21 | -7.38% | 6 | Oct 27, 2025 | |
| PHR Phreesia | Maintains: Buy | $35 → $36 | $17.14 | +110.04% | 7 | Sep 8, 2025 | |
| HIMS Hims & Hers Health | Maintains: Hold | $48 → $37 | $32.34 | +14.41% | 11 | Aug 18, 2025 | |
| WAY Waystar Holding | Maintains: Buy | $50 → $51 | $31.59 | +61.44% | 3 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $24 → $27 | $28.42 | -5.00% | 10 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $52 → $61 | $43.86 | +39.08% | 9 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $48 | $48.47 | -0.97% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $10 → $9 | $7.25 | +24.14% | 16 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.5 → $5.5 | $2.88 | +90.97% | 12 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $12 → $7.5 | $4.96 | +51.21% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $46 | $29.21 | +57.48% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $261 → $210 | $233.21 | -9.95% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $10.26 | +36.45% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.4 → $6.5 | $0.99 | +558.96% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $4.00 | +225.00% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $2.54 | +844.88% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $1.72 | +132.56% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $202.52 | -71.36% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $2.40 | +1,775.00% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $825.62 | -59.67% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $2.64 | +240.91% | 2 | May 19, 2021 |
Medline
Jan 12, 2026
Initiates: Buy
Price Target: $52
Current: $42.72
Upside: +21.72%
IQVIA Holdings
Jan 8, 2026
Maintains: Buy
Price Target: $265 → $290
Current: $240.86
Upside: +20.40%
ICON Public Limited Company
Jan 8, 2026
Downgrades: Hold
Price Target: $231 → $222
Current: $180.15
Upside: +23.23%
Fortrea Holdings
Jan 8, 2026
Upgrades: Buy
Price Target: $12 → $22
Current: $18.40
Upside: +19.57%
Privia Health Group
Nov 10, 2025
Reiterates: Buy
Price Target: $30 → $31
Current: $23.44
Upside: +32.28%
Evolent Health
Nov 10, 2025
Maintains: Buy
Price Target: $16 → $10
Current: $4.15
Upside: +140.96%
Medpace Holdings
Oct 27, 2025
Maintains: Hold
Price Target: $436 → $555
Current: $599.21
Upside: -7.38%
Phreesia
Sep 8, 2025
Maintains: Buy
Price Target: $35 → $36
Current: $17.14
Upside: +110.04%
Hims & Hers Health
Aug 18, 2025
Maintains: Hold
Price Target: $48 → $37
Current: $32.34
Upside: +14.41%
Waystar Holding
Jul 17, 2025
Maintains: Buy
Price Target: $50 → $51
Current: $31.59
Upside: +61.44%
Jul 17, 2025
Maintains: Hold
Price Target: $24 → $27
Current: $28.42
Upside: -5.00%
Jul 17, 2025
Maintains: Hold
Price Target: $52 → $61
Current: $43.86
Upside: +39.08%
Jun 16, 2025
Initiates: Buy
Price Target: $48
Current: $48.47
Upside: -0.97%
May 27, 2025
Maintains: Hold
Price Target: $10 → $9
Current: $7.25
Upside: +24.14%
Apr 10, 2025
Maintains: Hold
Price Target: $6.5 → $5.5
Current: $2.88
Upside: +90.97%
Apr 10, 2025
Maintains: Hold
Price Target: $12 → $7.5
Current: $4.96
Upside: +51.21%
Mar 18, 2025
Maintains: Buy
Price Target: $50 → $46
Current: $29.21
Upside: +57.48%
Jan 13, 2025
Maintains: Hold
Price Target: $261 → $210
Current: $233.21
Upside: -9.95%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $10.26
Upside: +36.45%
May 24, 2024
Maintains: Hold
Price Target: $6.4 → $6.5
Current: $0.99
Upside: +558.96%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $4.00
Upside: +225.00%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $2.54
Upside: +844.88%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $1.72
Upside: +132.56%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $202.52
Upside: -71.36%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $2.40
Upside: +1,775.00%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $825.62
Upside: -59.67%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $2.64
Upside: +240.91%